Authors:
Blumel, JE
Castelo-Branco, C
Roncagliolo, ME
Guanes, PP
Lavin, P
Citation: Je. Blumel et al., Do women using hormone replacement treatment have less pre-existing cardiovascular risk, MATURITAS, 38(3), 2001, pp. 315-319
Authors:
Castelo-Branco, C
Vicente, JJ
Vanrell, JA
Citation: C. Castelo-branco et al., Use of gonadotropin-releasing hormone analog with tibolone to prevent cyclic attacks of acute intermittent porphyria, METABOLISM, 50(9), 2001, pp. 995-996
Authors:
Castelo-Branco, C
Vicente, JJ
Pons, F
de Osaba, MJM
Casals, E
Vanrell, JA
Citation: C. Castelo-branco et al., Bone mineral density in young, hypothalamic oligoamenorrheic women treatedwith oral contraceptives, J REPRO MED, 46(10), 2001, pp. 875-879
Authors:
Castelo-Branco, C
Vicente, JJ
Figueras, F
Sanjuan, A
de Osaba, MJM
Casals, E
Pons, F
Balasch, J
Vanrell, JA
Citation: C. Castelo-branco et al., Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women, MATURITAS, 34(2), 2000, pp. 161-168
Authors:
Blumel, JE
Castelo-Branco, C
Gonzalez, P
Moyano, C
Iturriaga, M
Videla, L
Sanjuan, A
Cano, A
Citation: Je. Blumel et al., Transdermal estrogens do not appear to modify the extent of lesional areasof aortic atherosclerosis in oophorectomized rabbits on a cholesterol-richdiet, ATHEROSCLER, 148(2), 2000, pp. 303-308
Authors:
Castelo-Branco, C
Figueras, F
Sanjuan, A
Vicente, JJ
de Osaba, MJM
Pons, F
Balasch, J
Vanrell, JA
Citation: C. Castelo-branco et al., Long-term compliance with estrogen replacement therapy in surgical postmenopausal women: Benefits to bone and analysis of factors associated with discontinuation, MENOPAUSE, 6(4), 1999, pp. 307-311
Authors:
Castelo-Branco, C
Casals, E
Figueras, F
Sanjuan, A
Vicente, JJ
Balasch, J
Vanrell, JA
Citation: C. Castelo-branco et al., Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B, MENOPAUSE, 6(2), 1999, pp. 92-97
Authors:
Castelo-Branco, C
Figueras, F
Sanjuan, A
Pons, F
Vicente, JJ
Vanrell, JA
Citation: C. Castelo-branco et al., Long-term postmenopausal hormone replacement therapy effects on bone mass:differences between surgical and spontaneous patients, EUR J OB GY, 83(2), 1999, pp. 207-211
Authors:
Castelo-Branco, C
Pons, F
Vicente, JJ
Sanjuan, A
Vanrell, JA
Citation: C. Castelo-branco et al., Preventing postmenopausal bone loss with ossein-hydroxyapatite compounds -Results of a two-year, prospective trial, J REPRO MED, 44(7), 1999, pp. 601-605
Authors:
Castelo-Branco, C
de Osaba, MJM
Pons, F
Casals, E
Sanjuan, A
Vicente, JJ
Vanrell, JA
Citation: C. Castelo-branco et al., Ossein-hydroxyapatite compounds for preventing postmenopausal bone loss - Coadjuvant use with hormone replacement therapy, J REPRO MED, 44(3), 1999, pp. 241-246
Citation: A. Cano et al., Effect of menopause and different combined estradiol-progestin regimens onbasal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels, FERT STERIL, 71(2), 1999, pp. 261-267